Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

This study is testing an investigational oral drug called DCC-2812 in people with advanced genitourinary cancers — including kidney cancer, bladder/urinary tract cancer, or prostate cancer that no longer responds to hormone therapy. **You may be eligible if...** - You have confirmed advanced or metastatic renal cell carcinoma, urothelial cancer, or castration-resistant prostate cancer - You are able to swallow oral medication - Your organ function meets the required thresholds - If female and able to become pregnant, you have had a negative pregnancy test and will use contraception **You may NOT be eligible if...** - You have had recent anticancer treatment or an investigational therapy within the required timeframe - You have significant heart problems - You had major surgery within the past 28 days Talk to your doctor to see if this trial is right for you.